Tevogen Complements Capital Access with Two-Year Extension to Loan Agreement
Tevogen Inc TVGN
$5.99
▲ +2.57%
(+$0.15)
🎈 Low Float
📅 Earnings This Week
Open
$5.98
Prev Close
$5.84
Day Range
$5.97 – $5.99
52W Range
$3.64 – $27.40
Market Cap
$38.03M
Beta
0.30
EPS (TTM)
$-6.80
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-11-04 |
| Shares Out. | 6,510,000 |
| Website | tevogen.com/ ↗ |
| Phone | 18778386436 |
| Employees | 18 |
| Revenue | $0 |
| Gross Profit | $0 |
| Net Income | -$5.8M |
| Free Cash Flow | -$11.6M |
| Total Assets | $4.7M |
| Total Liabilities | $13.6M |
| Equity | -$8.9M |
About Tevogen Inc
Tevogen Inc is a healthcare enterprise engaged in biotechnology, artificial intelligence and technology, and healthcare services. Its operations focus on the development of biotechnology products, AI- and technology-based healthcare solutions, and healthcare service initiatives.
Tevogen Inc is a publicly traded company under the ticker symbol TVGN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2026-08-01)